Showing 481-490 of 1846 results for "".
A Growing Armamentarium for Psoriasis: How to Choose the Right Treatment for Each Patient
https://practicaldermatology.com/topics/psoriasis/a-growing-armamentarium-for-psoriasis-how-to-choose-the-right-treatment-for-each-patient/18214/Erin Boh, MD joins host Joshua Zeichner, MD in this edition of DermTube Journal Club to offer tips for navigating all the new and existing treatment options for patients with moderate to severe psoriasis. With so many effective options on the market, Dr. Boh says it's possible to find the best fit fLaser Innovations on the Horizon
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/laser-innovations-on-the-horizon/18534/Jill Waibel, MD discusses advances in lasers and what's on the horizon. She shares insights on a new and improved pulsed dye laser plus RF; fractional applications being investigated for scars, vitiligo, wrinkles, and more; plus devices for vaginal rejuvenation.The Menassaince
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-menassaince/18722/Men are an increasingly important demographic in aesthetics today, Steven Dayan, MD tells Dermtube host Joel Cohen, MD. Unlike their female counterparts, men tend to prefer one-and-done procedures and often seek treatment after hours, he says.PsO Many Options: The Expanded Psoriasis Landscape
https://practicaldermatology.com/topics/psoriasis/pso-many-options-the-expanded-psoriasis-landscape/18749/By Jeffrey Weinberg, MD and Seemal R. Desai, MDWith many new therapies coming out in oral, topical, and biologic forms, there are fewer unmet needs in psoriasis management now than ever before. Dr. Weinberg navigates the therapeutic landscape.Telemedicine and Access, Inappropriate Antibiotics, Industry Growth
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-telemedicine-and-access-inappropriate-antibiotics-industry-growth/18602/New research published online in JAMA Dermatology suggests that teledermatology improves access to care. Experts predict continued growth of telemedicine in dermatology. New estimates suggest that 30% of antibiotic prescriptions may be inappropriate. Dermatologists warn against antibiotic misuse andThe PA Salary: Structures and Strategies
https://practicaldermatology.com/topics/general-topics/the-pa-salary-structures-and-strategies/21597/Just as there is a wide range of practice settings that utilize a PA, there is an array of salary structures for PAs. Choose a structure that is fair and mutually beneficial.Embracing Change: Father-Son Dermatologists Reflect on Their Decades of Experience
https://practicaldermatology.com/topics/general-topics/embracing-change-father-son-dermatologists-reflect-on-their-decades-of-experience/24023/With Kenneth Beer, MD, and Jacob I. Beer, MDBy Heidi SpleteWhy Assessing Vitiligo Activity is Critical for Limiting Spread
https://practicaldermatology.com/conferences/maui-derm-2024/why-assessing-vitiligo-activity-is-critical-for-limiting-spread/20248/Chief Medical Editor Neal Bhatia, MD talks with “Mr. Vitiligo Himself,” John E. Harris, MD, PhD about the importance of determining whether vitiligo patients are active or stable in order to “shut off” spreading as soon as possible.DermWireTV: ASDS Meeting Highlights; Daxxify Data; PA Week
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-asds-meeting-highlights-daxxify-data-pa-week/20147/ASDS speakers address aesthetic advancements, skin cancer, and DEI with Joel L. Cohen, MD, Sherrif Ibrahim, MD, and Jeanine Downie, MD. On the heels of FDA approval of Revance’s Daxxify, data published in the Aesthetic Surgery Journal demonstrate the efficacy of DaxibotulinumtoxinA for patients of dScientifically Speaking: Managing Hair Loss Beyond PRP
https://practicaldermatology.com/series/scientifically-speaking/cientifically-speaking-managing-hair-loss-beyond-prp/20035/From documentary photographs to the potential for exosomes and the role of prescription therapies, many hot topics have emerged in the field of hair restoration. Glynis Ablon, MD and Jeffrey Rapaport, MD talk to host Joel L. Cohen, MD about clinical considerations beyond PRP.